Metabolism and mechanism of action of 5-fluorouracil.

This is a review on the mechanism of action of FUra. Three main areas are addressed: metabolism, RNA-directed actions of FUra, and DNA-directed actions of FUra. Key words for bibliographic purposes: metabolism, RNA, rRNA, mRNA, tRNA, DNA primase, DNA, thymidylate synthetase, uracil N-glycosylase, FUra, FUrd, FdUrd, FdUMP, RNA splicing, 5,10-methylene tetrahydrofolate, FUTP.

[1]  R. Diasio,et al.  Evidence from rat hepatocytes of an unrecognized pathway of 5-fluorouracil metabolism with the formation of a glucuronide derivative. , 1985, Cancer research.

[2]  D. Kufe,et al.  Biologic effect of 5-fluoro-2'-deoxyuridine incorporation in L1210 deoxyribonucleic acid. , 1983, Biochemical pharmacology.

[3]  S. Spiegelman,et al.  Improving the anti-tumor activity of 5-fluorouracil by increasing its incorporation into RNA via metabolic modulation. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[4]  L. Grossman,et al.  Enzymes involved in the repair of damaged DNA. , 1981, Archives of biochemistry and biophysics.

[5]  U. Lönn,et al.  DNA lesions in human neoplastic cells and cytotoxicity of 5-fluoropyrimidines. , 1986, Cancer research.

[6]  R. Diasio,et al.  5-Fluorouracil incorporation into DNA of CF-1 mouse bone marrow cells as a possible mechanism of toxicity. , 1984, Cancer research.

[7]  P. Danenberg,et al.  Evidence that intracellular synthesis of 5-fluorouridine-5'-phosphate from 5-fluorouracil and 5-fluorouridine is compartmentalized. , 1984, Biochemical and biophysical research communications.

[8]  Y. Cheng,et al.  Human thymidylate synthetase. II. Derivatives of pteroylmono- and -polyglutamates as substrates and inhibitors. , 1978, The Journal of biological chemistry.

[9]  I. I. Kaiser,et al.  Identification of 5‐flourocytidine in RNA from Escherichia coli grown in the presence of 5‐fluorouracil , 1973, FEBS letters.

[10]  F Valeriote,et al.  5-Fluorouracil (FUra). , 1984, Pharmacology & therapeutics.

[11]  B. Dolnick,et al.  5-Fluorouracil substitution alters pre-mRNA splicing in vitro. , 1988, The Journal of biological chemistry.

[12]  D. Kufe,et al.  5-Fluorouracil incorporation in DNA of human breast carcinoma cells. , 1982, Cancer research.

[13]  R. Glazer,et al.  Synergistic effect of 5-fluorouracil and N-(phosphonacetyl)-L-aspartate on cell growth and ribonucleic acid synthesis in human mammary carcinoma. , 1981, Biochemical pharmacology.

[14]  J. Grem,et al.  Enhancement of 5-fluorouracil's anticancer activity by dipyridamole. , 1989, Pharmacology & therapeutics.

[15]  B. Chabner,et al.  Assay of 5-fluorodeoxyuridine 5'-monophosphate deoxyuridine 5'-monophosphate pools following 5-fluorouracil. , 1974, Cancer research.

[16]  Y. Wataya,et al.  Imbalance of deoxyribonucleoside triphosphates, DNA double-strand breaks, and cell death caused by 2-chlorodeoxyadenosine in mouse FM3A cells. , 1989, Cancer research.

[17]  S. Spiegelman,et al.  Potentiation of the anti‐tumor activity of 5FU by thymidine and its correlation with the formation of (5FU) RNA , 1980, Cancer.

[18]  F. M. Huennekens,et al.  Overview: rational basis for development of fluoropyrimidine/5-formyltetrahydrofolate combination chemotherapy. , 1988, Advances in experimental medicine and biology.

[19]  P. Sharp,et al.  Splicing of messenger RNA precursors. , 1985, Harvey lectures.

[20]  H. Ingraham,et al.  2'-deoxyribosyl analogues of UDP-N-acetylglucosamine in cells treated with methotrexate or 5-fluorodeoxyuridine. , 1983, The Journal of biological chemistry.

[21]  R. Howell,et al.  Turnover of Ribosomal RNA in Rat Liver , 1965, Science.

[22]  P. Houghton,et al.  Biochemical determinants of responsiveness to 5-fluorouracil and its derivatives in xenografts of human colorectal adenocarcinomas in mice. , 1981, Cancer research.

[23]  R. Diasio,et al.  The effect of 5-fluorouracil on DNA chain elongation in intact bone marrow cells. , 1985, Biochemical and biophysical research communications.

[24]  H. G. Mandel,et al.  Effects of 5-fluorouracil on 5-fluorodeoxyuridine 5'-monophosphate and 2-deoxyuridine 5'-monophosphate pools, and DNA synthesis in solid mouse L1210 and rat Walker 256 tumors. , 1978, Cancer research.

[25]  P. Danenberg,et al.  Fluorinated pyrimidines as tight-binding inhibitors of thymidylate synthetase. , 1981, Pharmacology & therapeutics.

[26]  R. I. Glazer,et al.  Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture. , 1982, Molecular pharmacology.

[27]  P. Houghton,et al.  Characterization of the pools of 5,10-methylenetetrahydrofolates and tetrahydrofolates in xenografts of human colon adenocarcinoma. , 1988, Cancer research.

[28]  R. Diasio,et al.  Formation of conjugates of 2-fluoro-beta-alanine and bile acids during the metabolism of 5-fluorouracil and 5-fluoro-2-deoxyuridine in the isolated perfused rat liver. , 1988, Cancer research.

[29]  F. Berger,et al.  A naturally occurring variation in thymidylate synthase structure is associated with a reduced response to 5-fluoro-2'-deoxyuridine in a human colon tumor cell line. , 1988, Molecular pharmacology.

[30]  D. Kufe,et al.  Enhancement of 5-fluorouracil incorporation into human lymphoblast ribonucleic acid. , 1981, Biochemical pharmacology.

[31]  H. Krokan,et al.  Uracil DNa-glycosylase from HeLa cells: general properties, substrate specificity and effect of uracil analogs. , 1981, Nucleic acids research.

[32]  C. Heidelberger,et al.  Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory Compounds , 1957, Nature.

[33]  U. Lönn,et al.  Interaction between 5-fluorouracil and DNA of human colon adenocarcinoma. , 1984, Cancer research.

[34]  R. Diasio,et al.  Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion. , 1990, Cancer research.

[35]  B. Magasanik,et al.  THE ROLES OF INDUCER AND CATABOLITE REPRESSOR IN THE SYNTHESIS OF BETA-GALACTOSIDASE BY ESCHERICHIA COLI. , 1964, Journal of molecular biology.

[36]  D. Santi,et al.  Cytotoxicity of 5-fluoro-2'-deoxyuridine: requirement for reduced folate cofactors and antagonism by methotrexate. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[37]  B. Leyland-Jones,et al.  Role of thymidine in biochemical modulation: a review. , 1987, Cancer research.

[38]  D. Shugar,et al.  Infrared and ultraviolet studies on the tautomeric equilibria in aqueous medium between monoanionic species of uracil, thymine, 5-fluorouracil, and other 2,4-diketopyrimidines. , 1965, Journal of the American Chemical Society.

[39]  E. Cadman,et al.  Acute effect of 5-fluorouracil on cytoplasmic and nuclear dihydrofolate reductase messenger RNA metabolism. , 1986, The Journal of biological chemistry.

[40]  P. Danenberg,et al.  Deoxyuridylate effects on thymidylate synthase-5-fluorodeoxyuridylate-folate ternary complex formation. , 1989, Biochemical pharmacology.

[41]  P. Houghton,et al.  Effect of polyglutamylation of 5,10-methylenetetrahydrofolate on the binding of 5-fluoro-2'-deoxyuridylate to thymidylate synthase purified from a human colon adenocarcinoma xenograft. , 1989, Biochemical pharmacology.

[42]  Y. Cheng,et al.  Effects of 5-fluoro-2'-deoxyuridine on DNA metabolism in HeLa cells. , 1983, Molecular pharmacology.

[43]  R. Diasio,et al.  Metabolism of 5-fluorouracil to an N-cholyl-2-fluoro-beta-alanine conjugate: previously unrecognized role for bile acids in drug conjugation. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[44]  S. Greer,et al.  Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma. , 1987, Cancer research.

[45]  C. Takimoto,et al.  Precursor-dependent differences in the incorporation of fluorouracil in RNA. , 1986, Molecular pharmacology.

[46]  P. Plagemann,et al.  Nucleotide pools of Novikoff rat hepatoma cells growing in suspension culture. II. Independent snucleotide pools for nucleic acid synthesis , 1971 .

[47]  B. Leyland-Jones,et al.  Enhancement of the antitumor activity of 5-fluorouracil by uridine rescue. , 1989, Pharmacology & therapeutics.

[48]  J. Pink,et al.  Effects of 5-fluorouracil on dihydrofolate reductase and dihydrofolate reductase mRNA from methotrexate-resistant KB cells. , 1985, The Journal of biological chemistry.

[49]  D. Santi,et al.  Methods for the complete analysis of 5-fluorouracil metabolites in cell extracts. , 1981, Analytical biochemistry.

[50]  H. Pitot,et al.  Inhibition of ribosomal ribonucleic acid maturation in Novikoff hepatoma cells by 5-fluorouracil and 5-fluorouridine. , 1973, The Journal of biological chemistry.

[51]  D. Balinsky,et al.  Activities of some enzymes of pyrimidine and DNA synthesis in a rat transplantable hepatoma and human primary hepatomas, in cell lines derived from these tissues, and in human fetal liver. , 1980, Cancer research.

[52]  H. Mandel.  The Incorporation of 5-Fluorouracil Into RNA and its Molecular Consequences , 1969 .

[53]  R. Diasio,et al.  Circadian variation of 5-fluorouracil catabolism in isolated perfused rat liver. , 1989, Cancer research.

[54]  I. Eto,et al.  Determination of three different pools of reduced one-carbon-substituted folates. II. Quantitation and chain-length determination of the pteroylpolyglutamates of rat liver. , 1981, Analytical biochemistry.

[55]  W. Parker,et al.  Dissociation of 5-fluorouracil-induced DNA fragmentation from either its incorporation into DNA or its cytotoxicity in murine T-lymphoma (S-49) cells. , 1987, Cancer research.

[56]  B. Ardalan,et al.  An update on the biochemistry of 5-fluorouracil. , 1981, Cancer treatment reviews.

[57]  C. Takimoto,et al.  Fluoropyrimidine-mediated changes in small nuclear RNA. , 1986, Journal of Biological Chemistry.

[58]  Z. Wang,et al.  Uracil-DNA glycosylase inhibitor gene of bacteriophage PBS2 encodes a binding protein specific for uracil-DNA glycosylase. , 1989, The Journal of biological chemistry.

[59]  E. Friedberg,et al.  Inhibitor of uracil-DNA glycosylase induced by bacteriophage PBS2. Purification and preliminary characterization. , 1980, The Journal of biological chemistry.

[60]  B. Shane,et al.  Regulation of folylpoly-gamma-glutamate synthesis in mammalian cells. In vivo and in vitro synthesis of pteroylpoly-gamma-glutamates by Chinese hamster ovary cells. , 1982, The Journal of biological chemistry.

[61]  T. Lindahl.  DNA repair enzymes. , 1982, Annual review of biochemistry.

[62]  U. Lönn,et al.  The increased cytotoxicity in colon adenocarcinoma of methotrexate-5-fluorouracil is not associated with increased induction of lesions in DNA by 5-fluorouracil. , 1986, Biochemical pharmacology.

[63]  T. Watanabe,et al.  Effects of 5-fluorouracil on globin mRNA synthesis in murine erythroleukemia cells. , 1986, Biochemistry.

[64]  S. Greer,et al.  Metabolic channeling of 5-fluoro-2'-deoxycytidine utilizing inhibitors of its deamination in cell culture. , 1985, Molecular pharmacology.

[65]  Y. Wataya,et al.  Deoxyribonucleoside triphosphate imbalance. 5-Fluorodeoxyuridine-induced DNA double strand breaks in mouse FM3A cells and the mechanism of cell death. , 1987, The Journal of biological chemistry.

[66]  K. Danenberg,et al.  Effect of 5, 10-methylenetetrahydrofolate on the dissociation of 5-fluoro-2'-deoxyuridylate from thymidylate synthetase: evidence for an ordered mechanism. , 1978, Biochemistry.

[67]  P. Arenaz,et al.  Purification and properties of the human placental uracil DNA glycosylase. , 1987, Biochimica et biophysica acta.

[68]  R. I. Glazer,et al.  Analysis of the effect of 5-fluorouracil on the synthesis and translation of polysomal poly(A)RNA from Ehrlich ascites cells. , 1981, Molecular pharmacology.

[69]  Peter Murray-Rust,et al.  Intermolecular interactions of the carbon-fluorine bond: the crystallographic environment of fluorinated carboxylic acids and related structures , 1983 .

[70]  C. Will,et al.  5-Fluorouracil inhibits dihydrofolate reductase precursor mRNA processing and/or nuclear mRNA stability in methotrexate-resistant KB cells. , 1989, The Journal of biological chemistry.

[71]  P. Danenberg.  Thymidylate synthetase - a target enzyme in cancer chemotherapy. , 1977, Biochimica et biophysica acta.

[72]  H. Fraenkel-conrat,et al.  Biological consequences of incorporation of 5-fluorocytidine in the RNA of 5-fluorouracil-treated eukaryotic cells. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[73]  B. Leyland-Jones,et al.  Overview of current status and future direction of clinical trials with 5-fluorouracil in combination with folinic acid. , 1987, Cancer treatment reports.

[74]  D. Kufe,et al.  Incorporation of 5-fluorodeoxycytidine and metabolites into nucleic acids of human MCF-7 breast carcinoma cells. , 1986, Cancer research.

[75]  H. Ingraham,et al.  DNA fragmentation and cytotoxicity from increased cellular deoxyuridylate. , 1986, Biochemistry.

[76]  C. Baugh,et al.  The uptake of pteroyl(14-C)glutamic acid into rat liver and its incorporation into the natural pteroyl poly-gamma-glutamates of that organ. , 1974, Biochemistry.

[77]  K. Danenberg,et al.  Effect of 5-fluorouracil substitution on the self-splicing activity of Tetrahymena ribosomal RNA. , 1990, Cancer research.

[78]  D. Kerr.  5-Fluorouracil and folinic acid: interesting biochemistry or effective treatment? , 1989, British Journal of Cancer.

[79]  C. Heidelberger,et al.  Biochemical determinants of tumor sensitivity to 5-fluorouracil: ultrasensitive methods for the determination of 5-fluoro-2'-deoxyuridylate, 2'-deoxyuridylate, and thymidylate synthetase. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[80]  H. Ingraham,et al.  Nucleotide levels and incorporation of 5-fluorouracil and uracil into DNA of cells treated with 5-fluorodeoxyuridine. , 1982, Molecular pharmacology.

[81]  S. Spiegelman,et al.  Incorporation of 5-fluorouracil into murine bone marrow DNA in vivo. , 1984, Cancer research.

[82]  R. Diasio,et al.  Alteration of the secondary structure of newly synthesized DNA from murine bone marrow cells by 5-fluorouracil. , 1986, Cancer research.

[83]  R. Donehower,et al.  Biochemical interactions between N-(phosphonacetyl)-L-aspartate and 5-fluorouracil. , 1982, Molecular Pharmacology.

[84]  C. Will,et al.  5-Fluorouracil augmentation of dihydrofolate reductase gene transcripts containing intervening sequences in methotrexate-resistant KB cells. , 1986, Molecular pharmacology.

[85]  S. Yoshida,et al.  Enhancement of the incorporation of 5-fluorodeoxyuridylate into DNA of HL-60 cells by metabolic modulations. , 1983, Cancer research.

[86]  H. Ingraham,et al.  Mechanism for exclusion of 5-fluorouracil from DNA. , 1980, Cancer research.

[87]  B. Chabner,et al.  Biochemical determinants of 5-fluorouracil response in vivo. The role of deoxyuridylate pool expansion. , 1975, The Journal of clinical investigation.

[88]  D. Fernandes,et al.  Dissociation of thymidylate biosynthesis from DNA biosynthesis by 5-fluoro-2'-deoxyuridine and 5,8-dideazaisofolic acid. , 1986, Cancer research.

[89]  Masao Tanaka,et al.  Utilization of 5-Fluoro-2′-deoxyuridine Triphosphate and 5-Fluoro-2′-deoxycytidine Triphosphate in DNA Synthesis by DNA Polymerases α and β from Calf Thymus , 1981 .

[90]  Y. Cheng,et al.  The role of deoxyuridine triphosphate nucleotidohydrolase, uracil-DNA glycosylase, and DNA polymerase alpha in the metabolism of FUdR in human tumor cells. , 1980, Molecular pharmacology.

[91]  J. Laskin,et al.  Assessment of growth-limiting events caused by 5-fluorouracil in mouse cells and in human cells. , 1980, Cancer research.

[92]  C. Heidelberger,et al.  The incorporation of 5-fluoro-2'-deoxyuridine into DNA of mammalian tumor cells. , 1981, Biochemical and biophysical research communications.

[93]  J. Pink,et al.  5-fluorouracil modulation of dihydrofolate reductase RNA levels in methotrexate-resistant KB cells. , 1983, The Journal of biological chemistry.

[94]  J. Scott,et al.  The identification of the forms of folate found in the liver, kidney and intestine of the monkey and their biosynthesis from exogenous pteroylglutamate (folic acid). , 1974, Biochimica et biophysica acta.

[95]  R. Moran.  Leucovorin enhancement of the effects of the fluoropyrimidines on thymidylate synthase , 1989 .

[96]  S. Greer,et al.  Use of 5-fluorodeoxycytidine and tetrahydrouridine to exploit high levels of deoxycytidylate deaminase in tumors to achieve DNA- and target-directed therapies. , 1984, Cancer research.

[97]  Z. Dominski,et al.  Inhibition of pre-mRNA splicing by 5-fluoro-, 5-chloro-, and 5-bromouridine. , 1989, The Journal of biological chemistry.

[98]  J. Laskin,et al.  Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil. , 1981, Cancer research.

[99]  Y. Maehara,et al.  Activities of various enzymes of pyrimidine nucleotide and DNA syntheses in normal and neoplastic human tissues. , 1982, Gan.

[100]  J. Bertino,et al.  Enhancement of the antitumor effects of 5-fluorouracil by folinic acid. , 1990, Pharmacology & therapeutics.

[101]  P. Goldman.  The carbon-fluorine bond in compounds of biological interest. , 1969, Science.

[102]  R. Diasio,et al.  Dihydrofluorouracil, a fluorouracil catabolite with antitumor activity in murine and human cells. , 1985, Cancer research.

[103]  M. Kane,et al.  Effect of intracellular folate concentration on the modulation of 5-fluorouracil cytotoxicity by the elevation of phosphoribosylpyrophosphate in cultured human KB cells. , 1987, Cancer research.

[104]  C. Will,et al.  5-Fluorouracil augmentation of dihydrofolate reductase RNA containing contiguous exon and intron sequences in KB7B cells. , 1987, The Journal of biological chemistry.

[105]  C. Takimoto,et al.  Correlation between ribosomal RNA production and RNA-directed fluoropyrimidine cytotoxicity. , 1987, Biochemical pharmacology.

[106]  P. Barr,et al.  On the mechanism of inhibition of DNA-cytosine methyltransferases by cytosine analogs , 1983, Cell.

[107]  A. Calvert,et al.  Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies. , 1986, Cancer research.

[108]  C. Myers.  The pharmacology of the fluoropyrimidines. , 1981, Pharmacological reviews.

[109]  R. Diasio,et al.  Modulation of 5-fluorouracil catabolism in isolated rat hepatocytes with enhancement of 5-fluorouracil glucuronide formation. , 1985, Cancer research.

[110]  D. Kufe,et al.  5-Fluoro-2'-deoxyuridine incorporation in L1210 DNA. , 1981, The Journal of biological chemistry.

[111]  K. Keyomarsi,et al.  Folinic acid augmentation of the effects of fluoropyrimidines on murine and human leukemic cells. , 1986, Cancer research.

[112]  Y. Cheng,et al.  Uracil DNA-glycosylase. Purification and properties of this enzyme isolated from blast cells of acute myelocytic leukemia patients. , 1980, The Journal of biological chemistry.

[113]  L. Loeb,et al.  Endogenous carcinogenesis: molecular oncology into the twenty-first century--presidential address. , 1989, Cancer research.

[114]  C. Benz,et al.  The influence of methotrexate pretreatment on 5-fluorouracil metabolism in L1210 cells. , 1981, The Journal of biological chemistry.

[115]  J R Bertino,et al.  5-fluorouracil-methotrexate synergy: enhancement of 5-fluorodeoxyridylate binding to thymidylate synthase by dihydropteroylpolyglutamates. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[116]  K. Keyomarsi,et al.  Mechanism of the cytotoxic synergism of fluoropyrimidines and folinic acid in mouse leukemic cells. , 1988, The Journal of biological chemistry.

[117]  E. Frei,et al.  Selective expansion of 5,10-methylenetetrahydrofolate pools and modulation of 5-fluorouracil antitumor activity by leucovorin in vivo. , 1989, Cancer research.

[118]  J. Armand,et al.  19F NMR spectrometry evidence for bile acid conjugates of alpha-fluoro-beta-alanine as the main biliary metabolites of antineoplastic fluoropyrimidines in humans. , 1988, Drug metabolism and disposition: the biological fate of chemicals.

[119]  D. Kufe,et al.  Lethality associated with incorporation of 5-fluorouracil into preribosomal RNA. , 1984, Molecular pharmacology.